Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 2,051–2,075 of 7,816 matching trials · page 83 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Pharmacological Modulation of Brain Oscillations in Memory Processing NCT05594017 Scopolamine (0.4mg); Placebo Runs in: United States · 1 site |
EARLY_PHASE1 other |
RECRUITING | 60 | University of Texas Southwestern Medical Center OTHER |
2025-10-03 |
|
Creating a Global Research Database That Connects Genetic Information and Long-term Health Data to Improve Personalized Treatment for People With Serious Mental Illness NCT06641726 Not applicable- observational study Runs in: United Kingdom · 1 site |
NA other |
RECRUITING | 50,000 | Akrivia Health INDUSTRY |
2025-10-03 |
|
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD) NCT05531526 AR1001; Placebo Runs in: Canada; China; Czechia; Denmark; France; Germany; Italy; ... · 198 sites |
PHASE3 other |
ACTIVE_NOT_RECRUITING | 1,535 | AriBio Co., Ltd. INDUSTRY |
2025-10-02 |
|
Cognitive Therapy Software for Improving Cognitive Function for Patients With Mild Cognitive Impairment NCT06264557 SB-100; Educational book Runs in: South Korea · 12 sites |
NA other |
COMPLETED | 140 | Rowan INDUSTRY |
2025-10-02 |
|
Laser Acupuncture for Behavioral and Psychological Symptoms of Dementia NCT07204145 Laser Acupuncture (808 nm laser pen); Sham Laser Acupuncture Runs in: Taiwan · 2 sites |
NA other |
NOT_YET_RECRUITING | 60 | China Medical University Hospital OTHER |
2025-10-02 |
|
Benefits of Personalised Music in Dementia - a Feasibility Study NCT04132362 Personalised music listening; Using fMRI to investigate the effect ... Runs in: United Kingdom · 1 site |
NA other |
RECRUITING | 1,080 | Music for my Mind OTHER |
2025-10-01 |
|
Self and Autobiographical Memory in Dementia With Lewy Bodies and Alzheimer Disease: a Behavioral and Multimodal Neuroimaging Study NCT04616287 Neuropsychological assessment and Multimodal brain MRI Runs in: France · 1 site |
NA other |
COMPLETED | 61 | University Hospital, Strasbourg, France OTHER |
2025-10-01 |
|
Positive Dementia Caregiving: Clinical Trial of an Online Training Program NCT06409455 Positive Dementia Caregiving in 30 Days Runs in: Hong Kong · 1 site |
PHASE2 other |
COMPLETED | 274 | Education University of Hong Kong OTHER |
2025-10-01 |
|
tDCS Effect on Psychotic Symptoms in Dementia With Lewy Bodies (DLB), and Impacts on Caregiver Burden NCT06785948 active-tDCS; Sham-tDCS Runs in: Monaco · 1 site |
NA other |
RECRUITING | 30 | Association de Recherche Bibliographique pour les Neurosciences OTHER |
2025-10-01 |
|
TSPO Modulation in AD NCT07191821 XBD173 Runs in: United Kingdom · 1 site |
PHASE2 other |
ENROLLING_BY_INVITATION | 51 | Imperial College London OTHER |
2025-10-01 |
|
Oral Semaglutide in Patients With Alzheimer's Disease NCT07200622 Semaglutide (Rybelsus®); Placebo |
PHASE2 GLP-1 |
NOT_YET_RECRUITING | 60 | Imperial College London OTHER |
2025-10-01 |
|
Non-invasive Diagnosis of Parkinson's Disease NCT07201610 |
NA other |
NOT_YET_RECRUITING | 60 | Blekinge Institute of Technology OTHER |
2025-10-01 |
|
Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494 Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabo... Runs in: France · 1 site |
NA other |
RECRUITING | 700 | Assistance Publique Hopitaux De Marseille OTHER |
2025-10-01 |
|
Effects of Alpha-lactalbumin Intake on Metabolic and Cognitive Functions in Elderly NCT02082418 Alpha-lactalbumin; Whey; Casein Runs in: United States · 1 site |
NA other |
COMPLETED | 59 | Texas A&M University OTHER |
2025-09-30 |
|
Repetitive Transcranial Magnetic Stimulation for Dementia NCT02621424 RTMS; sham Runs in: United States · 1 site |
NA other |
COMPLETED | 32 | VA Office of Research and Development OTHER_GOV |
2025-09-30 |
|
REGEnLIFE RGn530 - Feasibility Pilot NCT03672474 Photobiomodulation REGEnLIFE RGn530 device; SHAM REGEnLIFE RGn530 device Runs in: France · 1 site |
NA other |
TERMINATED | 60 | University Hospital, Montpellier OTHER |
2025-09-30 |
|
WeCareAdvisor Study for Caregivers of People Living With Dementia NCT05012410 Immediate treatment group with High-Intensity Prompts; Immediate tr... Runs in: United States · 1 site |
NA other |
COMPLETED | 262 | Drexel University OTHER |
2025-09-30 |
|
A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease NCT04228666 HB-adMSCs Runs in: United States · 1 site |
PHASE1|PHASE2 other |
WITHDRAWN | 0 | Hope Biosciences LLC INDUSTRY |
2025-09-29 |
|
OCT-Angiography and Adaptive Optics in Patients With Memory Impairment NCT04389437 Ophthalmological exam; Blood pressure measurement Runs in: France · 1 site |
NA other |
RECRUITING | 450 | Fondation Ophtalmologique Adolphe de Rothschild NETWORK |
2025-09-29 |
|
Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT) NCT05127057 PRIME Parkinson Care; Usual Care Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 214 | University of Bristol OTHER |
2025-09-29 |
|
Efficacy of Gamification in Enhancing User Engagement NCT05422339 The MapHabit system (MHS) Runs in: United States · 1 site |
NA other |
COMPLETED | 60 | MapHabit, Inc. INDUSTRY |
2025-09-29 |
|
Development of a Novel Multidimensional Therapeutic Intervention Protocol for MCI NCT07196592 Olfactory stimulation; Temporal Interference,TI; Olfactory-TI Stimu... |
NA other |
NOT_YET_RECRUITING | 300 | Yuan Shen OTHER |
2025-09-29 |
|
Effectiveness of Engaging in Advance Care Planning Talks (ENACT) Group Visits in Primary Care for Older Adults With and Without Alzheimer's Disease NCT05421728 ENACT group visit; Mailed Resources Runs in: United States · 8 sites |
NA other |
ACTIVE_NOT_RECRUITING | 516 | University of Colorado, Denver OTHER |
2025-09-26 |
|
Cognitive and Vascular Functioning Following TBI NCT06034509 No intervention. This is an observational study. Runs in: United States · 1 site |
NA other |
RECRUITING | 300 | Walter Reed National Military Medical Center OTHER_GOV |
2025-09-26 |
|
Anti-viral Therapy in Alzheimer's Disease NCT03282916 Valacyclovir; Placebo Runs in: United States · 3 sites |
PHASE2 other |
COMPLETED | 120 | Columbia University OTHER |
2025-09-25 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial